ALK and Pleural effusion: To identify genes whose loss of function confers ALK-TKI tolerance or resistance, a genome-wide knockout CRISPR/Cas9 screening was performed (Figure 1A) in a patient-derived JFCR-028-3 cell line, which was obtained from pleural effusion.